Feature | Cardiac Imaging | March 16, 2019| By Greg Freiherr

How Machine Learning Empowers Echo Users Today

Future Apps in Artificial Intelligence Could Transform Cardiology Landscape

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography. Photo by Greg Freiherr

Greg Freiherr

Greg Freiherr

Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echocardiograpy. And machine learning, which is part of artificial intelligence (AI), is just getting started.

“Machine learning (ML) is completely changing the landscape of echocardiography as we speak,” Partho P. Sengupta, M.D., told Imaging Technology News/Diagnostic and Interventional Cardiology (ITN/DAIC), before his presentation at an American College of Cardiology (ACC) session on the current and future applications of machine learning in echocardiography. “It has already been embedded in systems. It works seamlessly in the background without even people knowing about its existence. People just do their work and it takes care of interpretation.”

Sengupta, chief of the cardiology at West Virginia University in Morgantown, W. Va., is widely recognized as an expert in echocardiography. Before joining WVU, he directed interventional echocardiography and cardiac ultrasound research at the Zena and Michael A. Wiener Cardiovascular Institute at the Mount Sinai School of Medicine in New York City.

ML algorithms, also referred to as smart algorithms due to the AI on which they are based, are already having a major impact on the practice of cardiology, he said in the scientific session Saturday, March 16 at #ACC19, the 2019 annual meeting of the American College of Cardiology.

“Machine learning algorithms are being integrated into the routine workflow of these systems,” he said. “So they are already here.”

 

How Machine Learning Improves Echo

Embedded in modern echo systems, today’s smart algorithms make data interpretation more efficient, thereby improving the ability of physicians to diagnose rare conditions and problems, Sengupta said. Cardiac diagnostics often begin with echocardiography, he noted.  In recent years, echo has evolved to deliver imagery in multiple dimensions (e.g., 3-D and 4-D) and from smaller packages, epitomized by smart phone. Machine learning is the IT expression of this development.

Sengupta and colleagues concluded in a 2016 paper that machine-learning (ML)  algorithms may help standardize assessments and support the quality of interpretations.  Although “everybody benefits,” he said, from the availability of these algorithms, novice readers with limited experience have the most to gain.

“It takes away the knowledge burden required to diagnose a condition,” Sengupta said, noting that ML algorithms provide decision support “as good as a very senior physician.”

These algorithms may automatically calculate measurements such as ejection fraction. Some may even hint at the underlying anomaly. In the future, machine learning algorithms may be able to make calculations that indicate heart failure, stroke and atrial fibrillation – possibly with percentages indicating future risks, based on the patient’s phenotype, he said.

 

Predictive Analytics Changing Cardiology

“We already use some calculators in cardiology for estimating risk, but in the very near future, it will be even more precise and more individualized,” Sengupta said. “My take is that within the next couple of years you will see a total transformation of predictive analytics.”

Echo machines might forecast that a particular patient has “a 90 percent probability of having a heart failure admission in the next three days,” he said. Such predictions would allow clinicians to focus on high-risk patients.

In the more distant future, ML algorithms may automatically recognize clinical disorders, Sengupta said. But physicians will likely be given the option whether to accept these algorithms’ conclusions. Although embedded in the workflow of the echo system, ready to be executed, their conclusions will be “suggestions that physicians will have the ability to override, if they don’t agree with them,” Sengupta said.

While speculative, this view of the future is an extension of what can already be done and what will soon be possible.

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Related content:

A 40,000 Foot View of Trends in Cardiology

Applications for Artificial Intelligence in Cardiovascular Imaging

Machine Learning Approaches in Cardiovascular Imaging

Technology Report: Artificial Intelligence (Video report published January 2019) 

PODCAST: Shortcomings of CTA in Cardiology

PODCAST: How Technology Is Changing Cardiology

ACC.19 Future Hub Hosts “Shark Tank” of Emerging Technologies In Cardiology

Related Content

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Overlay Init